Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07373639 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Long-term Follow-up Study in Patients Who Received BEAM-101

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a Long-term Follow-up (LTFU) study in patients who received BEAM-101 in the parent study (Study BTX-AUT-001). Eligible patients who received BEAM-101 will be asked to participate in this LTFU study prior to completing Study BTX-AUT-001. Patients who enter into this study will be followed for 13 years (a total of 15 years after receiving BEAM-101).
Trial Details
NCT Number NCT07373639
Lead Sponsor Beam Therapeutics Inc.
Conditions
(from sponsor)		 Hemoglobinopathy, Sickle Cell Disease
Related terms Anemia, Sickle Cell, Hemoglobinopathies
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov